10-Year study tracks health after obesity drug trial ends

NCT ID NCT04972721

Completed Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times

Summary

This study follows people who were in the SELECT trial for an anti-obesity medication. It does not provide any new treatment—instead, participants fill out health questionnaires every 6 months for up to 10 years. The goal is to see long-term effects like heart attacks, strokes, cancer, weight changes, and quality of life after stopping the study medicine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

AngioCor Blumenau

Blumenau, Santa Catarina, 89020-430, Brazil
CIP Centro Integrado de Pesquisas do Hospital de Base

São José do Rio Preto, São Paulo, 15090-000, Brazil
CPCLIN - Centro de Pesquisas Clínicas

São Paulo, São Paulo, 01228-200, Brazil
CPQuali Pesquisa Clínica Ltda

São Paulo, São Paulo, 01228-000, Brazil
Cárdio Pulmonar da Bahia

Salvador, Estado de Bahia, 40170130, Brazil
Departamento de Gastroenterologia - HCFMUSP

São Paulo, São Paulo, 05403-000, Brazil
Eurolatino Medical Research Center

Uberlândia, Minas Gerais, 38400-500, Brazil
Hospital São Vicente de Paulo

Passo Fundo, Rio Grande do Sul, 99010-080, Brazil
Hospital do Coração do Brasil

Brasília, Federal District, 70390-700, Brazil
Instituto Brasil de Pesquisa Clinica

Rio de Janeiro, 20241-180, Brazil
Instituto Dante Pazzanese de Cardiologia

São Paulo, São Paulo, 04012-909, Brazil
Instituto de Pesquisa Clínica de Campinas

Campinas, São Paulo, 13060-080, Brazil
Instituto do Coração - HCFMUSP

São Paulo, São Paulo, 05403-000, Brazil
MAster Centre for Latvia

Marupes, 2167, Latvia
Master Centre Netherlands

Alphen aan den Rijn, 2408 AV, Netherlands
Master Centre for Algeria

Algiers, 16035, Algeria
Master Centre for Argentina

Prov. de Buenos Aires, B1636DSU, Argentina
Master Centre for Australia

North Sydney, New South Wales, 2060, Australia
Master Centre for Brazil

Säo Paulo, São Paulo, 05001-100, Brazil
Master Centre for Canada

Mississauga, Ontario, L4W 4XI, Canada
Master Centre for Denmark

Copenhagen S, 2300, Denmark
Master Centre for Finland

Espoo, FI-02600, Finland
Master Centre for Germany PMS

Mainz, 55124, Germany
Master Centre for Greece

Vouliagment, 16671, Greece
Master Centre for Ireland

Dublin, D09 X8W3, Ireland
Master Centre for Italy

Rome, 00144, Italy
Master Centre for Japan

Tokyo, 1000005, Japan
Master Centre for Malaysia

Selangor Darul Ehsan, Malaysia
Master Centre for Norway

Rud, 1309, Norway
Master Centre for South Africa

Sandton, Gauteng, 2146, South Africa
Master Centre for Sweden

Malmö, 202 15, Sweden
Master Centre for Tawain

Taipei, 106, Taiwan
Master Centre for Thailand

Bangkok, 10500, Thailand
Master Centre for USA

Plainsboro, New Jersey, 08536, United States
Master Centre for United Kingdom

Gatwick, West Sussex, RH6 0PA, United Kingdom
Master centre for India

Bangalore, 560001, India
Novo Nordisk Croatia Ltd.

Zagreb, 10 020, Croatia
Núcleo de Pesquisa Clínica S/S

Curitiba, Paraná, 80730-150, Brazil

Conditions

Explore the condition pages connected to this study.

OBESITY OVERWEIGHT